|Articles|April 28, 2023
Supplements and Featured Publications
- Managed Care Considerations in the Management of CKD Associated With T2D
Managed Care Considerations in the Management of CKD Associated With T2D
Advertisement
This publication was paid for by and developed under the direction of Bayer. It was not peer reviewed. Financial support and promotional content direction were provided by members of Bayer Market Access team.
This AJMC® Clinical Brief describes ways in which payers can optimize management of patients with chronic kidney disease associated with type 2 diabetes.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads
2
Contributor: Reimagining Beneficiary Engagement in Accountable Care Models to Make America Healthy Again
3
MID Models Reduce Adverse Events, Lower Costs in Oncology: Kenneth Komorny, PharmD, BCPS
4
5 Things to Know About the Oral GLP-1 Era
5






